Relmada Therapeutics is a Biotech company based in New York, NY. It has raised $28M in total funding. Latest round: Growth.
Relmada Therapeutics funding overview
Relmada Therapeutics is a Biotech company based in New York, NY. Relmada Therapeutics has raised $28M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Growth announced in July 2025. The round record for Relmada Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include Janus Henderson Investors, OrbiMed. 2 distinct backers are named across the disclosed rounds.
Relmada Therapeutics at a glance
Total raised
$28M
Latest round
Growth
Latest round date
July 2025
Industry
Biotech
Headquarters
New York, NY
Notable investors
Janus Henderson Investors, OrbiMed
Frequently asked about Relmada Therapeutics funding
How much has Relmada Therapeutics raised?
Relmada Therapeutics has raised $28M in total disclosed funding across the rounds on record.
Who has invested in Relmada Therapeutics?
Janus Henderson Investors, OrbiMed are named among the investors backing Relmada Therapeutics.
What was the latest Relmada Therapeutics funding round?
The most recent disclosed round is a Growth, announced in July 2025.
Where is Relmada Therapeutics based?
Relmada Therapeutics is based in New York, NY.
What sector does Relmada Therapeutics operate in?
Relmada Therapeutics is tracked under Biotech from New York, NY, with $28M in disclosed funding.
When did Relmada Therapeutics last raise?
The last disclosed Relmada Therapeutics round closed in July 2025 at Growth.
Round data for Relmada Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in New York and backer lists below.
